Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
July 15, 1997
Accuracy of technicians versus pharmacists in checking syringes prepared for a dialysis program
S R Andersen, J V St Peter, M G Macres, et al.
Clinical Pharmacokinetics
|
June 1, 1992
Controversies in determination of epoetin (recombinant human erythropoietin) dosages
P A Abraham, W L St Peter, K A Redic-Kill, et al.
Therapeutic Drug Monitoring
|
November 1, 1991
Teicoplanin measurement in patients with renal failure: comparison of fluorescence polarization immunoassay, microbiological assay, and high-performance liquid chromatographic assay
W M Awni, W L St Peter, D R Guay, et al.
Clinical Nephrology
|
November 15, 2000
Hospitalization risks between Renagel phosphate binder treated and non-Renagel treated patients
A J Collins, W L St Peter, F W Dalleska, et al.
Kidney International
|
November 13, 2001
Trends in anemia at initiation of dialysis in the United States
G T Obrador, T Roberts, W L St Peter, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
July 15, 1997
Accuracy of technicians versus pharmacists in checking syringes prepared for a dialysis program
S R Andersen, J V St Peter, M G Macres, et al.
Clinical Pharmacokinetics
|
June 1, 1992
Controversies in determination of epoetin (recombinant human erythropoietin) dosages
P A Abraham, W L St Peter, K A Redic-Kill, et al.
Therapeutic Drug Monitoring
|
November 1, 1991
Teicoplanin measurement in patients with renal failure: comparison of fluorescence polarization immunoassay, microbiological assay, and high-performance liquid chromatographic assay
W M Awni, W L St Peter, D R Guay, et al.
Clinical Nephrology
|
November 15, 2000
Hospitalization risks between Renagel phosphate binder treated and non-Renagel treated patients
A J Collins, W L St Peter, F W Dalleska, et al.
Kidney International
|
November 13, 2001
Trends in anemia at initiation of dialysis in the United States
G T Obrador, T Roberts, W L St Peter, et al.
Page
of 2